Compliance Platform Leverage ePharmaSolutions' flagship ePharmaOne platform, 21 CFR Part 11–compliant, to win mid-market pharma and CRO opportunities by delivering regulatory-ready site identification, activation, training and management across a global network.

Global Reach The platform already hosts over 350,000 clinical researchers across 130 countries, offering a ready-made global footprint that can accelerate multi-country trials and expand sponsor and CRO partnerships.

Unified Ecosystem Markets the solution as an end-to-end platform that improves communication between sponsors, CROs and sites, enabling faster decision-making and reduced trial delays.

Mid-market Advantage With a mid-sized profile (11-50 employees, revenue in the hundreds of millions), ePharmaSolutions can be pitched as a faster, more customer-focused alternative to mega-vendors, offering quicker deployment, tighter integration and favorable ROI for growing sponsors and CROs.

Integration Opportunities Current tech stack signals opportunities to expand through partnerships with system integrators and integrations with LMS, EHR/EMR, marketing automation, and analytics platforms, to deepen adoption of ePharmaOne and generate cross-sell opportunities.